BuzzLuv !

Menu

Pharma

AstraZeneca bets on next-generation cancer therapy with $2 bn Fusion deal | Company News

by
Business Standard

[ad_1] AstraZeneca said on Tuesday it will buy Canadian drug developer Fusion Pharmaceuticals Inc for $2 billion in cash as the Anglo-Swedish drugmaker bets on next-generation cancer treatments. The deal gives AstraZeneca a foothold in the radiopharmaceutical drugs market, which has seen increasing investor interest since 2021 when data from Novartis’ treatment showed … Read more

Portfolio, new launches to help pharma company Abbott India’s stock | News on Markets

by
Business Standard

[ad_1] Premium Abbott’s December quarter performance was mixed. Revenues were in line with estimates and operational parameters better than expected | Representative image The stock of Abbott India, the largest listed multinational pharmaceutical company, hit its highest early February and has added over 25 per cent to its returns since the start of the year. … Read more